Open collaboration, non-dilutive funding can nurture more homegrown biotechs
Singapore
THE pandemic has put Singapore biotech research on the global stage, thanks to more open collaboration across the industry.
But biotech startups here could use more funding support, said panellists at the Deep Tech Summit, held in conjunction with the Singapore Week of Innovation & Technology (Switch) 2021.
TRENDING NOW
DBS, OCBC, UOB push STI to new highs as institutions pile in ahead of earnings
Eligible Singaporeans to receive up to S$850 in GSTV cash, up to S$450 in MediSave top-ups in August
Record Cat A COE: expiring EV perk, longer bidding interval behind ‘re-run of 2025 mania’
Supermarket and minimart chain Hao Mart faces fifth High Court lawsuit